Health-related quality of life in prostate cancer

References

• Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46:765–81.
   PubMed Web of Science ®Google Scholar
• Schröder FH. Prostate cancer around the world. An overview. Urol Oncol 2010;28:663–7.
   PubMed Web of Science ®Google Scholar
• Finnish Cancer Registry [Internet]. Cancer Statistics. Available from: http://www.cancerregistry.fi 2012. [cited 2012 Sept 13].
   Google Scholar
• Alibhai SM, Klotz LH. A systematic review of randomized trials in localized prostate cancer. Can J Urol 2004;11: 2110–7.
   PubMedGoogle Scholar
• Dahabreh IJ, Chung M, Balk EM, Yu WW, Mathew P, Lau J, et al.Active surveillance in men with localized prostate cancer: A systematic review. Ann Intern Med 2012;156: 582–90.
   PubMed Web of Science ®Google Scholar
• Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL. Systematic review: Comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 2008;148:435–8.
   PubMed Web of Science ®Google Scholar
• Albertsen PC, Aaronson NK, Muller MJ, Keller SD, Ware JE, Jr. Health-related quality of life among patients with metastatic prostate cancer. Urology 1997;49:207–16.
   PubMed Web of Science ®Google Scholar
• Sintonen H. Outcome measurement in acid-related diseases. PharmacoEconomics 1994;5:17–26.
   Google Scholar
• Sintonen H. The 15D instrument of health-related quality of life: Properties and applications. Ann Med 2001;33: 328–36.
   PubMed Web of Science ®Google Scholar
• Pickard AS, Neary MP, Cella D. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes 2007;21:70.
   Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al.The European Organization for Research and Treatment of Cancer QLQ-C30: A quality- of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365–76.
   PubMed Web of Science ®Google Scholar
• Fayers P, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley A, et al. The EORTC QLQ-C30 scoring manual. 3rd ed. Brussels: European Organisation for Research and Treatment of Cancer; 2001.
   Google Scholar
• Aromaa A, Koskinen S. Health and functional capacity in Finland. Baseline results of the Health 2000 health examination survey. Series B 12/2004. 2004:171 ed. 2004.
   Google Scholar
• Statistical Package for the Social Sciences [computer program]. Version 20, 2012.
   Google Scholar
• Saarni SI, Härkänen T, Sintonen H, Suvisaari J, Koskinen S, Aromaa A, et al.The impact of 29 chronic conditions on health-related quality of life: A general population survey in Finland using 15D and EQ-5D. Qual Life Res 2006; 15:1403–14.
   PubMed Web of Science ®Google Scholar
• Brazier J, Roberts J, Tsuchiya A, Busschbach J, Tsuchiya A, Brazier J, et al. A comparison of the EQ-5D and SF-6D across seven patient groups – comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets. Health Econ 2004;13:873–84.
   PubMed Web of Science ®Google Scholar
• Conner-Spady B, Suarez-Almazor ME. Variation in the estimation of quality-adjusted life-years by different preference-based instruments. Med Care 2003;41:791–801.
   PubMed Web of Science ®Google Scholar
• Lillegraven S, Kristiansen IS, Kvien TK. Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis. Ann Rheum Dis 2010;69:1762–7.
   PubMed Web of Science ®Google Scholar
• Marra CA, Esdaile JM, Guh D, Kopec JA, Brazier JE, Koehler BE, et al. A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. Med Care 2004;42:1125–31.
   PubMed Web of Science ®Google Scholar
• Tsuchiya A, Brazier J, Roberts J. Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets. J Health Econ 2006;25:334–46.
   PubMed Web of Science ®Google Scholar
• Vainiola T, Pettilä V, Roine RP, Räsänen P, Rissanen AM, Sintonen H. Comparison of two utility instruments, the EQ-5D and the 15D, in the critical care setting. Intensive Care Med 2010;36:2090–3.
   PubMed Web of Science ®Google Scholar
• Jayadevappa R, Bloom BS, Chhatre S, Fomberstein KM, Wein AJ, Malkowicz SB. Health related quality of life and direct medical care cost in newly diagnosed younger men with prostate cancer. J Urol 2005;174:1059–64.
   PubMed Web of Science ®Google Scholar
• Song L, Northouse LL, Braun TM, Zhang L, Cimprich B, Ronis DL, et al. Assessing longitudinal quality of life in prostate cancer patients and their spouses: A multilevel modeling approach. Qual Life Res 2011;20:371–81.
   PubMed Web of Science ®Google Scholar